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Introduction: Data on infective endocarditis (IE) in Southeast Asia are scarce.
Objectives: To describe the clinical epidemiology of IE in Lao PDR, a lower middle-income country.
Methods: A single centre retrospective study at Mahosot Hospital, Vientiane. Patients aged over 1 year of age
admitted 2006–2012 to Mahosot Hospital with deﬁnite or possible IE by modiﬁed Duke criteria were included.
Results: Thirty-six patients fulﬁlled the inclusion criteria; 33 (91.7%) had left-sided IE. Eleven (30.6%) had deﬁnite
IE and 25 (69.4%) possible left-sided IE. Median age was 25 years old [IQR 18–42]. Fifteen patients (41.7%) were
males. Underlying heart diseases included: rheumatic valve disease in 12 (33.3%), congenital heart disease in 7
(19.4%), degenerative valve disease in 3 (8.3%), and of unknown origin in 14 (38.9%) patients. Native valve IE
was present in 30 patients (83.3%), and prosthetic valve IE in 6 patients (16.7%). The most frequent pathogens
were Streptococcus spp. in 7 (19.4%). Blood cultures were negative in 22 patients (61.1%). Complications includ-
ed: heart failure in 11 (30.6%), severe valve regurgitation in 7 (19.4%); neurological event in 7 (19.4%); septic
shock or severe sepsis in 5 (13.9%); and cardiogenic shock in 3 patients (8.3%). No patient underwent heart
surgery. Fourteen (38.9%) had died by follow-up after a median of 2.1 years [IQR 1–3.2]; and 3 (8.3%) were
lost to follow-up.
Conclusions: Infective endocarditis, a disease especially of young adults and mainly caused by Streptococcus spp.,
was associated with rheumatic heart disease and had high mortality in Laos.© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC-BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Infective endocarditis (IE) is a rare but severe disease that still has a
high mortality, even in those with access to tertiary centres. The epide-
miology of IE has recently signiﬁcantly changed across North America
and Europe in affecting an increasingly ageing population with comor-
bidities. Presentation is nowadays often acute, characterized by high
rates of Staphylococcus aureus infection, cardiac complications, and
embolic events [1–3]. Guidelines for prevention and management ofch Centre, Inserm U970, 56 rue
el).
eliability and freedom from bias
land Ltd. This is an open access articlIE are based on Western-focused studies, with an increasing emphasis
on early heart surgery [4–7]. However, data from developing countries
are scarce [8–11]. Driven by other epidemiological characteristics, the
challenges and treatment options the physician encounters in middle
and low-income settings may differ greatly from those described in
the medical literature.
We describe the clinical characteristics of IE in patients admitted to a
tertiary teaching hospital, in Vientiane, the Lao PDR (Laos), a lower
middle-income country, and examined their long-term outcomes.
2. Methods
2.1. Objectives
Themain objectivewas to describe the characteristics of patients admittedwith IE to a
tertiary centre in Laos, a lower middle-income country.e under the CC-BY license (http://creativecommons.org/licenses/by/3.0/).
Table 1
Diagnostic criteria in 36 patients with deﬁnite or possible IE.
Typical organism in 2 separate culturesa, nf (%) 9 (25.0)
Persistently positive blood culturesb, n (%) 0
Positive blood culture that does not meet the major criteria 4 (11.1)
Echocardiogram positive for IEc, n (%) 24g (66.7)
New valvular regurgitation, n (%) 1 (2.8)
Predisposing heart condition, n (%) 24 (66.7)
Fever N38 °C, n (%) 31 (86.1)
Vascular phenomenad, n (%) 10 (27.8)
Immunological phenomenae, n (%) 1 (2.8)
a Including Streptococcus viridans, Streptococcus bovis, HACEK group, Staphylococcus aureus
or community-acquired enterococci.
b Deﬁned as microorganisms consistent with IE from persistently positive blood cultures.
c Deﬁned as one of the following: oscillating intracardiac mass on valve or supporting
structures, in the path of regurgitant jets, or on implanted material in the absence of an
alternative anatomic explanation; or abscess.
d Deﬁned as: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm,
intracranial haemorrhage, conjunctival haemorrhages, and Janeway's lesions.
e Deﬁned as glomerulonephritis, Osler's nodes, Roth's spots, and rheumatoid factor.
f Missing data in one case.
g One patient had perivalvular abscess with no vegetation seen. No. patient underwent
heart valve surgery or necropsy precluding fulﬁlment of pathological criteria.
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Patients aged over 1 year admitted from January 2006 to January 2012 to Mahosot
Hospitalwith deﬁnite or possible IE according to themodiﬁedDuke criteria were included
in the study [12]. Mahosot Hospital (17.960 N, 102.612 E), Vientiane, is a primary–tertiary
care teaching hospital, with ~400 beds including cardiology wards that provide cardiac
surgery, mostly by visiting teams, and infectious disease wards. The hospital has trans-
thoracic echocardiography; trans-oesophageal echocardiography is used by visiting
surgical teams. Blood cultures were performed using standard procedures and antibiotic
susceptibility patterns determined using Clinical and Laboratory Standards Institute
(CLSI) methods [13]. The clinical signiﬁcance of positive cultures was determined by a
team of physicians at the time of the result based on factors that included organism
identity and the number of samples growing the same organism. We tested (acute and
convalescent) sera for antibodies to Coxiella burnetii, Legionella pneumophila, Bartonella
quintana and Bartonella henselaeby indirect immunoﬂuorescence assay (IFA) as previously
described [14]. Speciﬁc antibodies to Brucellamelitensis andMycoplasma pneumoniaewere
detectedwith an immunoenzymatic antibody test and the PlatelliaM. pneumoniae IgM kit
(Bio-Rad, Marnes-la-Coquette), respectively. When the results of the tests described
above were negative, we performed Western blot using Bartonella species antigens, as
described [15,16].
Informed consent was given by the patient or the next of kin at the time of the blood
culture as part of a study of the aetiology of septicaemia. Ethical clearancewas provided by
the Ethical Review Committee of the Faculty of Medical Sciences, National University of
Laos (Vientiane, Laos) and the Oxford University Tropical Ethics Research Committee
(Oxford, United Kingdom). The authors of this manuscript have all certiﬁed that they
comply with the Principles of Ethical Publishing.
2.3. Data collection
The hospital charts of patients with a clinical diagnosis or suspicion of IE were retro-
spectively reviewed by two of the authors (MM and SR). Patients were identiﬁed through
the Echocardiography Laboratory logbooks and the blood culture database of theMicrobi-
ology Laboratory. For each patient, the following data were collected: demographics;
symptoms and signs, including details of comorbidities such as diabetes, treatment with
steroids, excess alcohol consumption, IV drug use, and HIV infection. Supplementary
data were collected through the hospital charts and the echocardiography logbooks:
heart valve disease and its aetiology; history of cardiac surgery; IE complications as severe
valve dysfunction, heart failure (including cardiogenic shock), septic shock or severe sep-
sis, neurological complication, and arterial embolism. Deﬁnitions of IE complicationswere
based on contemporary guidelines [4]. The type of echocardiography (transthoracic,
transoesophageal or both), valve involved, vegetation detected and its maximum length
were recorded. Patients with both left- and right-sided IE were assigned to the left-sided
group. Those with native valve IE and prosthetic valve IE were assigned to the latter. The
choice of valve affected was based upon the presence of vegetation, abscess and/or ﬁstula
on echocardiogram.When only transthoracic echocardiogramwas performed and none of
these structures were described, the choice of the valve affected was based upon the
presence of at least moderate valve disease or a prosthetic valve.
Outcomes measures were: in-hospital mortality, status when discharged (alive, un-
well, or moribund), relapse, and long-term mortality. Follow-up was undertaken as a
cross sectional study by contacting the patient and/or his/her next of kin. If the patient
was lost to follow-up, the date of the latest attendance to the clinic was recorded.
3. Statistical analyses
The results are reported as median and interquartile range (IQR) or
as numbers and percentages. Categorical variables were compared
using chi-square test or Fisher's exact test, and continuous variables
using Student t-test or Wilcoxon rank sum test, as appropriate. Signiﬁ-
cance was deﬁned as p-values less than 0.05. Statistical analyses were
performed using STATA SE/12.1 (StataCorp LP, College Station, TX).
4. Results
After review of 110patients' hospital charts, 36 fulﬁlled themodiﬁed
Duke criteria for IE and were included in the study; 11 (30.6%) had def-
inite IE and 25 (69.4%) possible IE (Table 1). Median age was 25 years
old [IQR 18–42]. Fifteen patients (41.7%) were males. Thirty-three out
of 36 patients (91.7%) had left-sided IE. Five (13.9%) patients were
diabetic, 2 (5.6%) were on steroids, and 1 (2.8%) admitted excessive al-
cohol consumption. No patient was on chronic replacement renal ther-
apy. No IV drug users or HIV positive patients were identiﬁed.
Underlying heart diseases included rheumatic valve disease in 12
(33.3%), congenital heart disease in 7 (19.4%) and degenerative valve
disease in 3 (8.3%) patients. Eight (22.2%) patients had no evidence of
underlying valve disease, and data was missing for 6 (16.7%). Infectiveendocarditis afﬂicted a prosthetic valve in 6 (16.7%) patients. The
presence of a vegetation, abscess or ﬁstula allowed to formally diagnose
mitral valve IE in 11 (30.6%), aortic valve IE in 9 (25%) and both themi-
tral and aortic valves in 2 patients (5.6%). Further 5 patients were diag-
nosed with mitral, 2 with aortic and mitral valve, and one with aortic
valve IE based on the severity of valve regurgitation or the presence of
a prosthetic valve, giving a total of 16 (44.4%) mitral, 10 (27.8%) aortic
valve, and 4 (11.1%) combined aortic and mitral valve IE. One patient
(2.8%) had unrepaired ventricular septal defect (VSD) IE with vegeta-
tions both on the VSD and the tricuspid valve. One patient had
unrepaired tetralogy of Fallot with no vegetation and was diagnosed
with left-sided IE. One patient hadmildmitral regurgitationwith a neu-
rological defect but no vegetation on TTE and was classiﬁed as having
left-sided IE. One patient presented with vegetation on pulmonary
ductus arteriosus. Two patients did not undergo TTE during their hospi-
tal stay.
Investigations included TTE in 34 (94.4%) patients. All patients had at
least one set of blood cultures. One (2.8%) patient underwent brain CT
scan. None underwent transoesophageal examination.
At the date when blood cultures were drawn, symptoms had been
present for 7 days (median [IQR 2–21]). Blood cultures were negative
in 22 out of 36 patients (61.1%, missing data in one case), of whom
4 had deﬁnite IE and 18 possible IE. One patient with blood culture
negative IE had evidence for B. henselae infection. Pathogens were iso-
lated on blood cultures from 13 (36.1%) patients: Streptococcus spp. in
7/13 (Streptococcus pyogenes in 2, Streptococcus oralis in 1, Streptococcus
mutans in 1, Streptococcus anginosus in 1, Streptococcus sanguinis in 1
and Streptococcus agalactiae in 1), followed by Escherichia coli in 2/13,
Enterococcus faecalis in 2/13, Staphylococcus aureus in 1/13 (2.7%), and
coagulase negative staphylococci in 1/13 (in a patient with a prosthetic
aortic valve). Serology gave no evidence for C. burnetii, L. pneumophila,
B. melitensis or M. pneumoniae infection in those with negative blood
cultures. The antimicrobial susceptibilities of the organisms isolated
were largely as expected for the species concerned. All seven Streptococ-
cus spp. tested for their penicillin minimum inhibitory concentration
(MIC) by Etest (bioMérieux, Basingstoke, UK) were fully susceptible
(MIC≤ 0.125mg/L). Both E. coli isolates were fully susceptible to ceftri-
axone and gentamicin by disk diffusion testing although both were re-
sistant to ampicillin. Both E. faecalis isolates were susceptible to
penicillin or ampicillin (MIC ≤ 4 mg/L) although one showed evidence
of high level resistance to gentamicin. Both Staphylococcus spp. had ox-
acillin MICs b1 mg/L.
Clinical complications during hospital stay included: heart failure
with no shock in 11 (30.6%); severe valve regurgitation in 7 (19.4%);
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5 (13.9%); and cardiogenic shock in 3 (8.3%) patients. Among the 11
patients with detailed echocardiography reports, valve obstruc-
tion was noted in 4/11; and 2/11 presented with large vegeta-
tions (i.e. N10 mm as the longest dimension), abscess or ﬁstula on TTE.
The initial antibiotic regimen given was available for 25 out of 36
patients, among whom 10 received a combination of ceftriaxone and
gentamicin; 5 ceftriaxone alone; 4 a combination of penicillin and
gentamicin; 1 a combination of ampicillin and gentamicin; 1 penicillin
alone; 1 cloxacillin alone; 1 a combination of cloxacillin and gentamicin;
1 a combination of cloxacillin and rifampicin; and 1 a combination of
ceftriaxone, gentamicin and doxycycline.
No patient underwent surgery either during the acute phase or after
completion of antibiotic treatment. The median length of hospital stay
was 16 days [IQR 9–21].
Nine (25.0%) patients died during their hospital stay whilst 14
(38.9%) had died by follow-up after a median of 2.1 years [IQR 1–3.2].
Three (8.3%) patients were lost to follow-up. Among the 10 patients
discharged unwell, 6 were dead at follow-up, 3 were alive, and 1 was
lost to follow-up. Five patients (13.9%) experienced IE relapse requiring
readmission. Causes of death were available in 6 out of 14 cases: heart
failure in 3 patients; shock in 1 patient; gastrointestinal bleed in 1
case; and ventricularﬁbrillation and acute renal failure in the remaining
patient. The only factor associated with long-term mortality on univar-
iate analysis was greater age (p = 0.02) (Table 2).
5. Discussion
We describe the ﬁrst series of patients with IE in Laos. Patients were
mostly young with mainly rheumatic heart disease as their underlying
condition and rare comorbidity. The main causative agents were
Streptococcus spp., but blood cultures remained negative in over half
the patients. No patient underwent transoesophageal echocardiography
as a routine diagnostic tool. Hospital stay was relatively short and the
rate of relapses was high. Due to lack of resident cardiac surgeons, sur-
gery could not be performed in the presence of clear indications such
as heart failure or cardiogenic shock. Mortality was extremely high,
reaching ~39% at 2 years follow-up.
These data highlight the marked differences in IE epidemiology
between developing and wealthy countries. The demographic charac-
teristics, high frequency of underlying rheumatic heart disease and
microbiological aetiology are consistent with reports from other devel-
oping countries [9,17–20,36].
Rheumatic heart disease, a neglected disease of poverty, remains the
most common underlying condition. However, prevention programmesTable 2
Clinical, echocardiographic and microbiological characteristics according to long-term
mortality.
Factor Alive at follow-up
n = 19
Dead at follow-up
n = 14
Age years, mean (SD) 28.4 (3.1) 42.8 (5.4)
Male, n (%) 7 (19.4) 6 (42.9)
SBP mm Hg, mean (SD) 103.3 (4.6) 108.2 (8.2)
HR pulse/min, mean (SD) 102.1 (5.6) 96.4 (4.9)
Temperature °C, mean (SD) 38.5 (1.1) 38.1 (0.9)
Deﬁnite IE, n (%) 5 (26.3) 5 (13.9)
NVE, n (%) 15 (78.9) 13 (92.9)
Streptococcal IE, n (%) 2 (10.5) 3 (21.4)
Rheumatic heart disease, n (%) 7 (72.6) 5 (35.7)
Complicated IEa, n (%) 7 (36.8) 9 (64.3)
Relapse IE, n (%) 3 (15.8) 1 (7.1)
Vegetation on TTE, n (%) 13 (68.4) 10 (71.4)
Discharged unwell, n (%) 3 (15.8) 6 (42.9)
SBP, systolic blood pressure mm Hg. HR, heart rate/min. NVE, native valve endocarditis.
a Deﬁned by one of the following: severe valve regurgitation, septic shock or severe
sepsis, heart failure with no shock, cardiogenic shock, neurological complication,
valve obstruction, large vegetations (i.e., N10 mm), abscess or ﬁstula.reduce the burden of the disease. Control of rheumatic heart disease
can be achieved through cost-effective, register-based, primary and
secondary prevention programmes that deliver penicillin [21]. Congen-
ital heart disease was the second most frequent underlying aetiology,
probably because of the inclusion of children in our series.
The high frequency of streptococcal species in the Lao patients prob-
ably in part reﬂects poor oral health [22], suggesting the interest of pro-
moting dental hygiene education and awareness. Over half the patients
had negative blood cultures. This ﬁnding is consistent with other series
from developing countries [8,9,11,19]. Over the counter antibiotics are
available in Laos and self-medication is common [23], and may have
contributed to the low frequency of positive blood cultures, although
the retrospective design of our study did not allow this to be assessed.
Some of the pathogens identiﬁed, such as E. coli and S. pyogenes, have
been described as causing IE but are rare in industrialised country case
series [24,25]. On the basis of the results of this series, initial empirical
treatment of patients with suspected endocarditis with ceftriaxone
and gentamicin would be appropriate in Laos, adjusted on the basis of
susceptibilities if an organism is grown.
Access to imaging techniques was relatively low, with no
transoesophageal echocardiography performed. Only a minority of pa-
tients (1 out of 7) with clinical neurological complications underwent
a brain CT scan. Contrary to international guidelines [4,5], cephalospo-
rins were frequently the ﬁrst line of treatment, because of the logistic
difﬁculties of providing repeated infusions of penicillin. Median length
of stay was 16 days, suggesting that many patients did not receive a
minimum of 14 days of intravenous treatment, likely responsible for
the high rate of relapses (13.9%).
Access to cardiac surgery remains limited in Laos. No patient in
this series underwent cardiac surgery either during acute IE or after
completion of antibiotic treatment.
Outcomes were poor with approximately 39% of patients dead at
follow-up. These ﬁndings are worrying considering the clinical charac-
teristics of the disease: young patients with streptococcal infections,
and barely any comorbid conditions. Indeed, viridans streptococcal IE
has been documented as having a good prognosis when compared to
other causative microorganisms [1]. Younger age also should be associ-
atedwith higher chances of survival according to other series [1,26]. The
deadly toll in this series is consistent with reports from other develop-
ing countries [18,19,27,28].
In contrast to our ﬁndings, Thuny and colleagues recently outlined
the tremendous progress achieved in the management of IE in wealthy
countries [7]. Mortality is as low as 8.2% in some high-volume centres
[29]. Early surgery has become amainstay in the therapy of complicated
IE [4,5,30]. Such improvement is nonetheless largely restricted to the
wealthy world. In many developing countries, limited access to health
facilities, lack of adequate diagnostic tools such as transthoracic and
transoesophageal echocardiography, inadequate laboratory facilities to
perform trustworthy blood cultures and susceptibility testing and insuf-
ﬁcient skilled staff hamper early reliable diagnoses. Antibiotics are not
necessarily appropriate or of good quality [23,31]. The treatment course
is commonly interrupted prematurely as patients cannot afford the par-
enteral antibiotics, inpatient charges and family income loss associated
with prolonged hospitalisation. These results suggest the need for pro-
spective studies assessing reasons for early discharge in developing
countries and what engagement strategies may help to reduce this.
Importantly, access to cardiac surgery is limited in most low- and
lower-middle income countries. For instance, surgical facilities are re-
stricted to only 15 out of 55 African states, often supported by visiting
teams from Europe or North America [32].
Prevention of rheumatic heart disease and access to dental health
servicesmay reduce the incidence of IEworldwide. Considerable invest-
ment in national referral centres for access to diagnosis, inexpensive,
good quality, antibiotics and resources to support patients with long
term therapy and offset income loss are likely to be vital in reducing
the burden of this curable neglected infectious disease.
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This study is one of the very few reports on IE from Southeast Asian
developing countries [18,33–35]. It provides valuable data on the clini-
cal characteristics of IE in Laos. Although retrospective, follow-up data
was available in the majority of patients providing long-term mortality
rates. Access to diagnostic techniques was limited hence patients with
possible IE were included in the study. This study has a number of
limitations. The sample size was relatively small and therefore predic-
tors of mortality could not be thoroughly assessed. The inclusion of
children in our series may have overrepresented, in comparison to se-
ries of only adults, congenital heart disease as an underlying cause of
IE. We cannot rule out the possibility of a referral bias. Visiting surgical
teams from Europe (Luxembourg and France) have been working at
our institution on a regular basis for the past 10 years with an emphasis
on curable congenital defects.
7. Conclusion
Infective endocarditis has a high mortality rate in Laos, especially
afﬂicting young adults with rheumatic heart disease and mainly caused
by Streptococcus spp. Ways to reduce the burden of disease through
rheumatic heart disease prevention, promotion of oral health, and treat-
ment options by increasing diagnostic and therapeutic capacities need
to be addressed in developing countries.
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